Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) posted Gross Margin of 74.13% for Q2 2012, up 75.66 percentage points from -1.53% a year earlier but down 1.29 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011) Analysis & Trends

For the trailing twelve months through Nov 30, 2011, Gross Margin at Mosaic ImmunoEngineering was 39.37%.

  • Quarterly Gross Margin has run from a low of -1.53% in Q2 2011 to a high of 75.41% in Q1 2012 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 68.19%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 74.74%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 73.54%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 78.02%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 83.60%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 85.33%
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 74.13%
Aug 31, 2011 75.41%
Nov 30, 2010 -1.53%
Aug 31, 2010 1.86%
API Access

Mosaic ImmunoEngineering Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CPMV&period=max&api_key=YOUR_API_KEY